ReviewPharmaceuticals (Basel, Switzerland)2022

The STING in Non-Alcoholic Fatty Liver Diseases: Potential Therapeutic Targets in Inflammation-Carcinogenesis Pathway.

Juan Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.